Zhu et al. suggested that EYA4 suppressed HCC tumor cell growth by repressing MYCBP by dephosphorylating β‐catenin, S552, and HCC patients with high expression of EYA4 had significantly longer DFS and OS compared to HCC patients with low expression of EYA448. This evidence concerns the gene EYA4 and hepatocellular carcinoma.